Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Tax-Free Zones Split Drug Makers Over Excise Tax Cuts

This article was originally published in PharmAsia News

Executive Summary

Although the organization representing India's pharmaceutical industry presents a united voice before the government and its budget proposals, individual firms appear to disagree over the latest tax proposal. India's Union Budget proposal contains a provision proposing a 16 percent excise tax on drug makers not located in tax-free zones. The Indian Drug Manufacturers' Association takes the position the tax should be cut in half for small and medium firms not normally found in tax-free zones. A unified industry proposed a reduction of excise taxes for all drug makers, but the Finance Ministry did not respond, so several large drug makers entered tax-free zones. (Click here for more

You may also be interested in...



FDA Reveals Details Of Shilpa’s Violations

The FDA has revealed details of its recent warning letter to Shilpa, which cites the company’s failure to adequately investigate out-of-specification results and complaints as well as to follow written procedures for complaint handling.

Stada UK Partners With Diabetes Charity To Promote Foot Health

Diabetes-related foot amputations are on the rise in the UK. Stada through its UK subsidiary Thornton & Ross is partnering with Diabetes UK to promote foot health and the benefits of using its leading OTC foot-care brand, Flexitol. 

Coronavirus Update: Moderna Still Confident Of November Readout

The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.

UsernamePublicRestriction

Register

LL1134468

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel